Drug intelligence / Profile preview

APOHEALTH Osteo Relief Paracetamol

Development stage
Unknown
Lead developer
Arrotex
Modality
Small Molecules
Administration
Oral
01

Overview

APOHEALTH Osteo Relief Paracetamol is a modified-release formulation of paracetamol (acetaminophen) developed by Arrotex Pharmaceuticals (following the merger of Apotex Australia and Arrow Pharmaceuticals). Each tablet contains 665 mg of paracetamol, designed with a combination of immediate-release and sustained-release layers to provide persistent pain relief for up to 8 hours. It is primarily indicated for the management of persistent pain associated with osteoarthritis, as well as muscle aches, backache, and other mild-to-moderate pain conditions. Paracetamol acts predominantly in the central nervous system to inhibit prostaglandin synthesis by targeting cyclooxygenase (COX) enzymes, thereby reducing pain and fever without significant peripheral anti-inflammatory effects.

Brand names
APOHEALTH Osteo Relief Modified ReleaseAPOHEALTH Osteo Relief Paracetamol
Other names
acetaminophenparacetamol
02

Targets

CNR1 (Cannabinoid receptor 1)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on APOHEALTH Osteo Relief Paracetamol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on APOHEALTH Osteo Relief Paracetamol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call